Page 246 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Viral Hepatitis: Hepatitis C - Clinical (Except Therapy)

P0726 DISCREPANCIES OF DATA ON THE EXISTENCE OF
P0727 COMPLEX NATIONAL APPROACH TO HEPATITIS C
TREATMENT DERIVED FROM GOVERNMENTAL,
PROFESSIONAL/CIVIL SOCIETY AND PATIENT
INSTITUTIONS IN 33 EUROPEAN COUNTRIES
Jerneja Videčnik Zorman*, Sergeja Gregorčič, Mojca Matičič, Slovenia

CLINICAL UTILITY OF THE ARTUS HCV QS-RGQ ASSAY
FOR HCV RNA QUANTIFICATION
Johannes Vermehren*, Dany Perner, Duncan Clark, Simone Susser,
Jonathan Hubb, Stefan Zeuzem, Graham Foster, Christoph Sarrazin,
Germany

P0728 INVESTIGATION OF GENETIC RECOMBINATION OF
HEPATITIS C VIRUS IN PATIENTS INFECTED WITH
GENOTYPES 1, 2 AND 4
Julia Dietz*, Nabila Hamdi, Kai-Henrik Peiffer, Simone Susser,
Caterina Berkowski, Dany Perner, Stefan Zeuzem, Christoph Sarrazin,
Germany

ePOSTERS P0729 RENAL DISEASE PREVALENCE AND ASSOCIATION WITH
HEPATIC FIBROSIS MEASURED BY FIB4 SCORE AMONG
US PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV)
INFECTION IN THE CHRONIC HEPATITIS COHORT STUDY
(CHECS)
Scott D. Holmberg*, Anne C. Moorman, Xin Tong, Philip R. Spradling,
Eyasu H. Teshale, Stuart C. Gordon, Joseph A. Boscarino,
Vinutha Vijayadeva, Mark A. Schmidt, Loralee B. Rupp, Mei Lu,
Fujie Xu, The United States

P0730 PREVALENCE AND CHARACTERISTICS OF HEPATITIS C
GENOTYPES IN THE CHRONIC HEPATITIS COHORT STUDY
(CHECS)
Stuart Gordon*, Jia Li, Loralee B. Rupp, Joseph A. Boscarino,
Vinutha Vijayadeva, Mark A. Schmidt, Lois E. Lamerato, Mei Lu,
The United States

P0731 LEDIPASVIR (LDV)/SOFOSBUVIR (SOF) TREATMENT
OF HEPATITIS C VIRUS (HCV) IS ASSOCIATED WITH
REDUCTION OF SERUM APOLIPOPROTEIN LEVELS
Zobair Younossi*, Elzafir Elsheikh, Maria Stepanova, Lynn Gerber,
Fatema Nader, Diana Brainard, John G. McHutchinson,
The United States

246 The International Liver Congress™ 2015 • ILC Programme